KNIGHT THERAPEUTICS INCKNIGHT THERAPEUTICS INCKNIGHT THERAPEUTICS INC

KNIGHT THERAPEUTICS INC

No trades
See on Supercharts

Price target

7.600.000.00%
The 7 analysts offering 1 year price forecasts for GUD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to GUD in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


GUD EPS for the last quarter is −0.02 CAD despite the estimation of 0.02 CAD. In the next quarter EPS is expected to reach 0.02 CAD. Track more of KNIGHT THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter KNIGHT THERAPEUTICS INC revenue is expected to reach ‪88.94 M‬ CAD. Check out KNIGHT THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, GUD price target is 7.60 CAD with a max estimate of 9.00 CAD and a min estimate of 6.75 CAD. Check if this forecast comes true in a year, meanwhile watch KNIGHT THERAPEUTICS INC stock price chart and keep track of the current situation with GUD news and stock market news.
We've gathered opinions of 7 analysts rating GUD stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.